Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss

被引:90
作者
Mavri, A
Alessi, MC
Bastelica, D
Geel-Georgelin, O
Fina, F
Sentocnik, JT
Stegnar, M
Juhan-Vague, I
机构
[1] Univ Med Ctr, Dept Angiol, Ljubljana 1000, Slovenia
[2] Fac Med, Haematol Lab, Marseille, France
[3] Fac Med, Expt Cancerol Lab, Marseille, France
[4] Med Aestet Ctr, Ljubljana, Slovenia
关键词
PAI-1; abdominal; femoral; adipose tissue; obesity; weight reduction;
D O I
10.1007/s001250100007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis. Abdominal fat produces plasminogen activator inhibitor-1 (PAI-1) and could contribute to increased plasma PAI-1 values in human obesity associated with insulin resistance. Femoral fat, which is not associated with insulin resistance, is thought to be metabolically different from the abdominal fat. This study aimed to assess PAI- I expression in these two fat territories in obese and lean subjects and to determine if concomitant changes of plasma and adipose tissue PAI- I values occur after weight reduction. Methods. In 24 obese and 16 lean subjects. PAI- I expression in abdominal and femoral subcutaneous fat, plasma PAI-1, insulin, triglyceride concentrations and insulin resistance were determined at the start of the study and in obese subjects after a 3-month weight reduction programme as well. Results. PAI-1 mRNA content in the abdominal subcutaneous fat was higher in obese than in lean subjects and positively correlated with plasma PAI- I values (p < 0.01) and markers of insulin resistance (p < 0.05). In 18 obese subjects, re-examined after successful dieting, PAI-1 mRNA content decreased in the abdominal subcutaneous fat along with plasma PAI-1. However, the absolute changes of these two variables were not associated. In contrast, PAI-I mRNA content in the femoral subcutaneous fat did not differ between lean and obese subjects, was not associated with plasma PAI-1 values or with markers of insulin resistance, and did not change after weight loss. Conclusion/interpretation. Only the abdominal, but not the femoral subcutaneous fat PAI- I expression is a potential contributor to increases in plasma PAI-1 in obesity. Both plasma and abdominal subcutaneous fat PAI-1 values decreased significantly after weight reduction, although their absolute changes were not associated.
引用
收藏
页码:2025 / 2031
页数:7
相关论文
共 35 条
[1]   Plasminogen activator inhibitor 1, transforming growth factor-β1, and BMI are closely associated in human adipose tissue during morbid obesity [J].
Alessi, MC ;
Bastelica, D ;
Morange, P ;
Berthet, B ;
Leduc, I ;
Verdier, M ;
Geel, O ;
Juhan-Vague, I .
DIABETES, 2000, 49 (08) :1374-1380
[2]   Production of plasminogen activator inhibitor 1 by human adipose tissue - Possible link between visceral fat accumulation and vascular disease [J].
Alessi, MC ;
Peiretti, F ;
Morange, P ;
Henry, M ;
Nalbone, G ;
JuhanVague, I .
DIABETES, 1997, 46 (05) :860-867
[3]   Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 gene during very low calorie diet in obese subjects [J].
Bastard, JP ;
Vidal, H ;
Jardel, C ;
Bruckert, E ;
Robin, D ;
Vallier, P ;
Blondy, P ;
Turpin, G ;
Forest, C ;
Hainque, B .
INTERNATIONAL JOURNAL OF OBESITY, 2000, 24 (01) :70-74
[4]  
CALLESESCANDON J, 1996, AM J CLIN NUTR, V64, P17
[5]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[6]   Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men [J].
Cigolini, M ;
Targher, G ;
Andreis, IAB ;
Tonoli, M ;
Agostino, G ;
DeSandre, G .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (03) :368-374
[7]   Expression of plasminogen activator inhibitor-1 in human adipose tissue:: a role for TNF-α? [J].
Cigolini, M ;
Tonoli, M ;
Borgato, L ;
Frigotto, L ;
Manzato, F ;
Zeminian, S ;
Cardinale, C ;
Camin, M ;
Chiaramonte, E ;
De Sandre, G ;
Lunardi, C .
ATHEROSCLEROSIS, 1999, 143 (01) :81-90
[8]   Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals [J].
Eriksson, P ;
Reynisdottir, S ;
Lönnqvist, F ;
Stemme, V ;
Hamsten, A ;
Arner, P .
DIABETOLOGIA, 1998, 41 (01) :65-71
[9]   IMPACT OF WEIGHT-LOSS ON PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1), FACTOR-VII, AND OTHER HEMOSTATIC FACTORS IN MODERATELY OVERWEIGHT ADULTS [J].
FOLSOM, AR ;
QAMHIEH, HT ;
WING, RR ;
JEFFERY, RW ;
STINSON, VL ;
KULLER, LH ;
WU, KK .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (02) :162-169
[10]   Effect of tumor necrosis factor alpha and transforming growth factor beta 1 on plasminogen activator inhibitor-1 secretion from subcutaneous and omental human fat cells in suspension culture [J].
Gottschling-Zeller, H ;
Birgel, M ;
Röhrig, K ;
Hauner, H .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (05) :666-671